Taysha Gene Therapies, Inc.
USD6.87
+0.14 (+2.08%)
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.79
Prev. Close
$6.73
Day Low
$6.74
Day High
$6.90
52W Low
$2.25
52W High
$7.30
Market Cap
$1.72B
Volume
0.26M
| 42,671 |
| $5.97 |
| 2 Jun 2026 | Donenberg Phillip B. | director | A-Award | Acquired | 21,335 | $0.00 |
| 2 Jun 2026 | Donenberg Phillip B. | director | A-Award | Acquired | 42,671 | $5.97 |
| 2 Jun 2026 | Long Alison S | director | A-Award | Acquired | 21,335 | $0.00 |
| 2 Jun 2026 | Long Alison S | director | A-Award | Acquired | 42,671 | $5.97 |
| 2 Jun 2026 | Sepp-Lorenzino Laura | director | A-Award | Acquired | 21,335 | $0.00 |
| 2 Jun 2026 | Sepp-Lorenzino Laura | director | A-Award | Acquired | 42,671 | $5.97 |
| 13 Apr 2026 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | Acquired | 19,021 | $1.71 |
| 13 Apr 2026 | Nagendran Sukumar | director, officer: President and Head of R&D | S-Sale | Disposed | 200,000 | $4.46 |